BR112023020229A2 - Processos para a preparação de um composto bicíclico de cetona quiral, composto de n-amino lactama quiral, composto de sal imidato e composto hidroxicetoéster, composto, ou um sal farmaceuticamente aceitável do mesmo e invenção - Google Patents
Processos para a preparação de um composto bicíclico de cetona quiral, composto de n-amino lactama quiral, composto de sal imidato e composto hidroxicetoéster, composto, ou um sal farmaceuticamente aceitável do mesmo e invençãoInfo
- Publication number
- BR112023020229A2 BR112023020229A2 BR112023020229A BR112023020229A BR112023020229A2 BR 112023020229 A2 BR112023020229 A2 BR 112023020229A2 BR 112023020229 A BR112023020229 A BR 112023020229A BR 112023020229 A BR112023020229 A BR 112023020229A BR 112023020229 A2 BR112023020229 A2 BR 112023020229A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- chiral
- processes
- pharmaceutically acceptable
- salt
- Prior art date
Links
- -1 KETONE COMPOUND Chemical class 0.000 title abstract 6
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 150000003839 salts Chemical class 0.000 title abstract 3
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/46—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
- C07D207/50—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163170422P | 2021-04-02 | 2021-04-02 | |
| PCT/US2022/022997 WO2022212809A1 (en) | 2021-04-02 | 2022-04-01 | Processes for making bicyclic ketone compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023020229A2 true BR112023020229A2 (pt) | 2023-11-14 |
Family
ID=81385014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023020229A BR112023020229A2 (pt) | 2021-04-02 | 2022-04-01 | Processos para a preparação de um composto bicíclico de cetona quiral, composto de n-amino lactama quiral, composto de sal imidato e composto hidroxicetoéster, composto, ou um sal farmaceuticamente aceitável do mesmo e invenção |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20240034739A1 (enExample) |
| EP (1) | EP4313986A1 (enExample) |
| JP (1) | JP2024513394A (enExample) |
| KR (1) | KR20230165238A (enExample) |
| CN (1) | CN117098762A (enExample) |
| AR (1) | AR125294A1 (enExample) |
| AU (1) | AU2022246900A1 (enExample) |
| BR (1) | BR112023020229A2 (enExample) |
| CA (1) | CA3214802A1 (enExample) |
| IL (1) | IL307250A (enExample) |
| MX (1) | MX2023011482A (enExample) |
| TW (1) | TW202304921A (enExample) |
| WO (1) | WO2022212809A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026139459A1 (en) | 2024-12-23 | 2026-07-02 | Astrazeneca Ab | Heterocyclic inhibitors of ripk1 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3155107B2 (ja) | 1993-01-12 | 2001-04-09 | ダイセル化学工業株式会社 | 光学活性４−ハロ−３−ヒドロキシ酪酸エステルの製造方法 |
| JPH08336393A (ja) | 1995-04-13 | 1996-12-24 | Mitsubishi Chem Corp | 光学活性なγ−置換−β−ヒドロキシ酪酸エステルの製造法 |
| JP3915015B2 (ja) | 1995-08-22 | 2007-05-16 | 味の素株式会社 | 光学活性２−ヒドロキシ−４−アリール酪酸またはそのエステルの製造方法 |
| CA2234913A1 (en) * | 1995-10-18 | 1997-04-24 | Paul E. Finke | Cyclopentyl tachykinin receptor antagonists |
| US5891685A (en) | 1996-06-03 | 1999-04-06 | Mitsubishi Chemical Corporation | Method for producing ester of (S)-γ-halogenated-β-hydroxybutyric acid |
| DE19857302C2 (de) | 1998-12-14 | 2000-10-26 | Forschungszentrum Juelich Gmbh | Verfahren zur enantioselektiven Reduktion von 3,5-Dioxocarbonsäuren, deren Salze und Ester |
| AU1551701A (en) | 1999-12-03 | 2001-06-12 | Kaneka Corporation | Novel carbonyl reductase, gene thereof and method of using the same |
| AU2007201854A1 (en) * | 2000-10-17 | 2007-05-17 | Merck Serono Sa | Pharmaceutically active sulfanilide derivatives |
| HUP0400261A3 (en) | 2001-03-22 | 2005-11-28 | Bristol Myers Squibb Co | Stereoselective reduction of substituted acetophenone |
| US20080050787A1 (en) | 2003-12-02 | 2008-02-28 | Hazuki Nagai | Method for Manufacturing Optically Active Tetrahydrothiophene Derivative and Method for Crystallization of Optically Active Tetrahydrothiophene-3-Ol |
| WO2006130657A2 (en) | 2005-05-31 | 2006-12-07 | Bristol-Myers Squibb Company | Stereoselective reduction process for the preparation of pyrrolotriazine compounds |
| CN101627116B (zh) | 2007-02-08 | 2013-07-10 | 科德克希思公司 | 酮还原酶及其用途 |
| JP2010070502A (ja) * | 2008-09-19 | 2010-04-02 | Daiichi Sankyo Co Ltd | 抗真菌作用トリアゾロピリジン誘導体 |
| RU2515976C2 (ru) * | 2009-02-26 | 2014-05-20 | Эйсай Ар Энд Ди Менеджмент Ко., Лтд. | Азотсодержащие конденсированные гетероциклические соединения и их применение в качестве ингибиторов продукции бета-амилоида |
| TWI648274B (zh) | 2013-02-15 | 2019-01-21 | 英商葛蘭素史克智慧財產發展有限公司 | 作為激酶抑制劑之雜環醯胺類 （二） |
| RU2716136C2 (ru) | 2015-07-02 | 2020-03-06 | Ф. Хоффманн-Ля Рош Аг | Бициклические лактамы и способы их применения |
| US11071721B2 (en) * | 2016-12-02 | 2021-07-27 | Genentech, Inc. | Bicyclic amide compounds and methods of use thereof |
| CN119613408A (zh) * | 2017-07-14 | 2025-03-14 | 豪夫迈·罗氏有限公司 | 二环酮化合物及其使用方法 |
| WO2019072942A1 (en) * | 2017-10-11 | 2019-04-18 | F. Hoffmann-La Roche Ag | BICYCLIC COMPOUNDS FOR USE AS INHIBITORS OF KINASE RIP1 |
| CN113302193B (zh) * | 2019-01-11 | 2026-05-29 | 豪夫迈·罗氏有限公司 | 双环吡咯并三唑酮化合物及其使用方法 |
| CN111606890A (zh) * | 2019-02-26 | 2020-09-01 | 微境生物医药科技(上海)有限公司 | 含丙烯酰基的核转运调节剂及其用途 |
-
2022
- 2022-04-01 CA CA3214802A patent/CA3214802A1/en active Pending
- 2022-04-01 AR ARP220100830A patent/AR125294A1/es unknown
- 2022-04-01 BR BR112023020229A patent/BR112023020229A2/pt unknown
- 2022-04-01 WO PCT/US2022/022997 patent/WO2022212809A1/en not_active Ceased
- 2022-04-01 MX MX2023011482A patent/MX2023011482A/es unknown
- 2022-04-01 KR KR1020237033599A patent/KR20230165238A/ko active Pending
- 2022-04-01 CN CN202280025356.3A patent/CN117098762A/zh active Pending
- 2022-04-01 IL IL307250A patent/IL307250A/en unknown
- 2022-04-01 JP JP2023560507A patent/JP2024513394A/ja active Pending
- 2022-04-01 TW TW111112842A patent/TW202304921A/zh unknown
- 2022-04-01 EP EP22718464.5A patent/EP4313986A1/en active Pending
- 2022-04-01 AU AU2022246900A patent/AU2022246900A1/en active Pending
-
2023
- 2023-10-02 US US18/479,596 patent/US20240034739A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022246900A8 (en) | 2023-09-21 |
| KR20230165238A (ko) | 2023-12-05 |
| CA3214802A1 (en) | 2022-10-06 |
| EP4313986A1 (en) | 2024-02-07 |
| JP2024513394A (ja) | 2024-03-25 |
| AR125294A1 (es) | 2023-07-05 |
| MX2023011482A (es) | 2023-10-03 |
| CN117098762A (zh) | 2023-11-21 |
| AU2022246900A1 (en) | 2023-09-14 |
| TW202304921A (zh) | 2023-02-01 |
| WO2022212809A1 (en) | 2022-10-06 |
| IL307250A (en) | 2023-11-01 |
| US20240034739A1 (en) | 2024-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112022010254A2 (pt) | Composto heterocíclico contendo oxigênio representado pela fórmula i, método para preparar o composto heterocíclico contendo oxigênio, composto, composição farmacêutica e uso composto heterocíclico contendo oxigênio | |
| BR112023015976A2 (pt) | Compostos de anel aromático de pirimidina | |
| SA521431048B1 (ar) | مركبات بيروليدين | |
| BR112022006202A2 (pt) | Compostos heterocíclicos de arila como bloqueadores de canal do agitador de potássio kv1,3 | |
| BR112017023540A2 (pt) | síntese de derivados de 1 h-pirrolo[2,3-b]piridin que modulam quinases | |
| BR112022006507A2 (pt) | Compostos heterocíclicos de arilmetileno como bloqueadores de canais de agitador de potássio kv1.3 | |
| BR112022006242A2 (pt) | Compostos aromáticos de arilmetileno como bloqueadores de canal do agitador de potássio kv1,3 | |
| BR112022012385A2 (pt) | Método de preparação e aplicação de composto de agente de degradação de proteínas | |
| BR112018070677A2 (pt) | inibidores de mcl-1 macrocíclicos para o tratamento de câncer | |
| BR112015021596A2 (pt) | moduladores de gpr120 de ácido oxabiciclo[2.2.2] | |
| BR112022006292A2 (pt) | Compostos heterobicílicos de arila como bloqueadores de canais de agitador de potássio kv1.3 | |
| AR079205A1 (es) | Morfolinotiazoles como moduladores alostericos positivos alfa 7 | |
| BR112014014909A2 (pt) | agonistas de tgr5 não sistêmicos | |
| BR112012024403A2 (pt) | processo de preparo de derivados de amino-benzofurano | |
| BR112022008061A2 (pt) | Processo eficaz para síntese de 2-amino-5-cloro-n,3-dimetilbenzamida | |
| MX2021000348A (es) | 2-fluoro-3-nitrotolueno cristalino y procedimiento para la preparacion del mismo. | |
| BR112016024936A2 (pt) | moduladores de gpr40 à base de pirrolidina para tratamento de doenças como diabetes | |
| BR112013011593A2 (pt) | cristal de derivado de morfinan 7-carbamoíla-6,7-insaturada e método para produzir o mesmo | |
| BR112023023729A2 (pt) | Novo intermediário para preparação de piroxasulfona | |
| SA523451905B1 (ar) | Cdk2 مركبات بيريميدينيل-بيرازول بها استبدال كمثبطات | |
| BR112019025028A2 (pt) | Método para preparar um composto. | |
| MX2019013816A (es) | Compuesto usado como regulador de la autofagia, metodo de preparacion y sus usos. | |
| BR112022006250A2 (pt) | Compostos heterobicíclicos de arila como bloqueadores de canal de agitador de potássio kv1.3 | |
| BR112021018578A2 (pt) | Compostos de heterociclil(fenil)metanol úteis no tratamento de hiperglicemia | |
| CL2024002461A1 (es) | Síntesis de compuestos de quinazolina |